Notice: Memcache::connect() [memcache.connect]: Server 192.168.72.165 (tcp 11212) failed with: Connection refused (111) in /www/sites/www.stockpickr.com/docroot/sites/all/modules/contrib/memcache/dmemcache.inc on line 250

Warning: Memcache::connect() [memcache.connect]: Can't connect to 192.168.72.165:11212, Connection refused (111) in /www/sites/www.stockpickr.com/docroot/sites/all/modules/contrib/memcache/dmemcache.inc on line 250
Undervalued Biotech's Portfolio - 2009 Stock Picks and Performance - Stockpickr!

Undervalued Biotech's

Description:

With the merger between Pfizer (PFE) and Wyeth (WYE), the attempted takeover of Genentech (DNA) by Roche, and the overall positive action in Amgen (AMGN), Celgene Corp (CELG), Genzyme (GENZ), and Geilead (GILD) recently, many analysts and investors believe that 2009 will be a positive year for the biotech industry as a whole.
Important events in the biotech space include Dendreon’s (DNDN) binary data announcement on its key drug Provenge in early April and Genentech’s (DNA) update on various uses for Avastin late April.

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks to Buy for Earnings Season Gains

10.20.14 | 11:16 AM

BALTIMORE (Stockpickr) -- All eyes are on earnings season to start Monday, as investors hope that new earnings calls could help buoy stocks this we...

5 Stocks Ready to Break Out and Soar Higher

10.20.14 | 10:25 AM

DELAFIELD, Wis. (Stockpickr) -- Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high or takes...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter